Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.

MLA

Chu, Zhaoxing, et al. “Design, Synthesis and Biological Evaluation of Novel Benzoxaborole Derivatives as Potent PDE4 Inhibitors for Topical Treatment of Atopic Dermatitis.” European Journal of Medicinal Chemistry, vol. 213, Mar. 2021, p. 113171. EBSCOhost, https://doi.org/10.1016/j.ejmech.2021.113171.

APA

Chu, Z., Xu, Q., Zhu, Q., Ma, X., Mo, J., Lin, G., Zhao, Y., Gu, Y., Bian, L., Shao, L., Guo, J., Ye, W., Li, J., He, G., & Xu, Y. (2021). Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis. European Journal of Medicinal Chemistry, 213, 113171. https://doi.org/10.1016/j.ejmech.2021.113171

Chicago

Chu, Zhaoxing, Qinlong Xu, Qihua Zhu, Xiaodong Ma, Jiajia Mo, Gaofeng Lin, Yan Zhao, et al. 2021. “Design, Synthesis and Biological Evaluation of Novel Benzoxaborole Derivatives as Potent PDE4 Inhibitors for Topical Treatment of Atopic Dermatitis.” European Journal of Medicinal Chemistry 213 (March): 113171. doi:10.1016/j.ejmech.2021.113171.